Chemocentryx Inc. buy marge
Start price
21.06.15
/
50%
€7.75
Target price
21.12.15
€9.80
Performance (%)
-10.29%
End price
21.12.15
€6.95
Summary
This prediction ended on 21.12.15 with a price of €6.95. The prediction for Chemocentryx Inc. disappointed with a performance of -10.29%. marge has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Chemocentryx Inc. | - | - | - | - |
iShares Core DAX® | -0.612% | 0.567% | 12.585% | 14.838% |
iShares Nasdaq 100 | -3.018% | -3.205% | 26.208% | 38.328% |
iShares Nikkei 225® | -2.647% | 0.330% | 9.482% | 5.652% |
iShares S&P 500 | -1.932% | -1.126% | 23.191% | 38.791% |
Comments by marge for this prediction
In the thread Chemocentryx Inc. diskutieren
Chemocentryx Inc.
Aus meinem Langfristportofolio mit den Large-cap biotechs:
1.Gilead Science (40%)
2. Amgen (15%)
3. Celgene (25%),
und den smaller-cap biotechs:
Isis Pharmaceuticals, ChemoCentryx, Acceleron,
Portola Pharmaceuticals, Cempra, Supernus mit anteiliger Gesamtgewichtung von 20%
Nachfragen zu den einzelnen Werten beantworte ich gerne.
(Laufzeit überschritten)